Michelle is a life sciences strategy consultant with extensive experience in advising biopharmaceutical clients on how to develop innovative strategies to inform new product planning, life cycle management and commercialization. As a Senior Engagement Manager, she exclusively concentrates in managing project delivery for key oncology accounts. She has served oncology clients from pre-revenue biotechnology companies to big pharma across multiple solid and liquid tumors and drug classes representing various biological mechanisms of action. She was previously an Associate Principal at Promidian (now Eversana Consulting) and a Senior Consultant in the Life Sciences Practice at Navigant (now Guidehouse) where she worked on client engagements across multiple therapeutic areas including rare diseases, metabolic diseases, behavioral health and oncology. Michelle is a graduate of the Vagelos Life Sciences & Management program at the University of Pennsylvania's Wharton School where she earned a dual degree of B.Sc in Economics with a specialization in Healthcare and Operations and a B.S in Biological Basis of Behavior.